As of 2025-10-13, the Intrinsic Value of Pliant Therapeutics Inc (PLRX) is -16.86 USD. This PLRX valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.47 USD, the upside of Pliant Therapeutics Inc is -1,246.68%.
Based on its market price of 1.47 USD and our intrinsic valuation, Pliant Therapeutics Inc (PLRX) is overvalued by 1,246.68%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -16.86 - -16.86 | -16.86 | -1,246.68% |
| P/E | (68.30) - (70.80) | (71.64) | -4973.4% |
| DDM - Stable | (42.29) - (200.03) | (121.16) | -8342.4% |
| DDM - Multi | (41.30) - (151.89) | (64.94) | -4517.7% |
| Market Cap (mil) | 90.24 |
| Beta | 1.30 |
| Outstanding shares (mil) | 61.39 |
| Enterprise Value (mil) | 33.78 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.55% |
| Cost of Debt | 5.00% |
| WACC | 6.58% |